通过系统回顾对临床FLASH质子治疗中当前知识差距和缓解策略的影响评估。

IF 3.5 3区 医学 Q2 ONCOLOGY
Frontiers in Oncology Pub Date : 2025-09-11 eCollection Date: 2025-01-01 DOI:10.3389/fonc.2025.1550264
Anne H Zur Horst, Steven J M Habraken, Marta Rovituso, Yvonne L B Klaver, Kees H Spruijt, Mischa S Hoogeman
{"title":"通过系统回顾对临床FLASH质子治疗中当前知识差距和缓解策略的影响评估。","authors":"Anne H Zur Horst, Steven J M Habraken, Marta Rovituso, Yvonne L B Klaver, Kees H Spruijt, Mischa S Hoogeman","doi":"10.3389/fonc.2025.1550264","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>Following first clinical trials, the development of FLASH proton therapy (FLASH-PT) into a mature treatment modality is ongoing, while physical and biological conditions underlying the FLASH effect remain uncertain. Our aim is to assess the impact of these uncertainties on clinical FLASH-PT through a novel approach.</p><p><strong>Methods: </strong>A systematic literature review was conducted to collect relevant <i>in vivo</i> preclinical studies as well as FLASH-PT treatment planning and delivery approaches. This information was used to perform an impact assessment: the FLASH-PT process from patient selection to treatment delivery was divided into steps, and seven FLASH conditions were defined. The FLASH conditions included physical, delivery-related, and radiobiological aspects. For each step and FLASH condition, scores were assigned based on the (i) criticality for clinical applications, (ii) current knowledge, and (iii) available mitigation strategies. These scores were combined to obtain an overall impact for all FLASH conditions ranging from insignificant impact not affecting clinical routine to severe impact causing severe complications for clinical translation.</p><p><strong>Results: </strong>In total, 14 preclinical and 27 treatment planning studies were identified. From these, 47 combined scores were reported in the impact assessment. A severe impact was found for patient selection in the context of radiobiological uncertainties for the robustness of the FLASH effect with respect to beam pauses and interruptions and for the evaluation of dose rate due to their importance in the treatment process combined with remaining unknowns. Moderate to insignificant impact was found for fractionation and FLASH-PT treatment delivery mode (transmission or Bragg peak beams), as these offer strategies to circumvent uncertainties. Overall, dose requirements, the use of multiple fields, and dose rate conditions emerged as the most crucial factors.</p><p><strong>Conclusions: </strong>Since uncertainties about the FLASH conditions hinder the utilization of its full pre-clinical potential in clinical practice, focusing future preclinical experiments to gain further phenomenological rather than only mechanistic insights on these aspects is recommended.</p>","PeriodicalId":12482,"journal":{"name":"Frontiers in Oncology","volume":"15 ","pages":"1550264"},"PeriodicalIF":3.5000,"publicationDate":"2025-09-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12460130/pdf/","citationCount":"0","resultStr":"{\"title\":\"Impact assessment of current knowledge gaps and mitigation strategies in clinical FLASH proton therapy through a systematic review.\",\"authors\":\"Anne H Zur Horst, Steven J M Habraken, Marta Rovituso, Yvonne L B Klaver, Kees H Spruijt, Mischa S Hoogeman\",\"doi\":\"10.3389/fonc.2025.1550264\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Introduction: </strong>Following first clinical trials, the development of FLASH proton therapy (FLASH-PT) into a mature treatment modality is ongoing, while physical and biological conditions underlying the FLASH effect remain uncertain. Our aim is to assess the impact of these uncertainties on clinical FLASH-PT through a novel approach.</p><p><strong>Methods: </strong>A systematic literature review was conducted to collect relevant <i>in vivo</i> preclinical studies as well as FLASH-PT treatment planning and delivery approaches. This information was used to perform an impact assessment: the FLASH-PT process from patient selection to treatment delivery was divided into steps, and seven FLASH conditions were defined. The FLASH conditions included physical, delivery-related, and radiobiological aspects. For each step and FLASH condition, scores were assigned based on the (i) criticality for clinical applications, (ii) current knowledge, and (iii) available mitigation strategies. These scores were combined to obtain an overall impact for all FLASH conditions ranging from insignificant impact not affecting clinical routine to severe impact causing severe complications for clinical translation.</p><p><strong>Results: </strong>In total, 14 preclinical and 27 treatment planning studies were identified. From these, 47 combined scores were reported in the impact assessment. A severe impact was found for patient selection in the context of radiobiological uncertainties for the robustness of the FLASH effect with respect to beam pauses and interruptions and for the evaluation of dose rate due to their importance in the treatment process combined with remaining unknowns. Moderate to insignificant impact was found for fractionation and FLASH-PT treatment delivery mode (transmission or Bragg peak beams), as these offer strategies to circumvent uncertainties. Overall, dose requirements, the use of multiple fields, and dose rate conditions emerged as the most crucial factors.</p><p><strong>Conclusions: </strong>Since uncertainties about the FLASH conditions hinder the utilization of its full pre-clinical potential in clinical practice, focusing future preclinical experiments to gain further phenomenological rather than only mechanistic insights on these aspects is recommended.</p>\",\"PeriodicalId\":12482,\"journal\":{\"name\":\"Frontiers in Oncology\",\"volume\":\"15 \",\"pages\":\"1550264\"},\"PeriodicalIF\":3.5000,\"publicationDate\":\"2025-09-11\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12460130/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Frontiers in Oncology\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.3389/fonc.2025.1550264\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2025/1/1 0:00:00\",\"PubModel\":\"eCollection\",\"JCR\":\"Q2\",\"JCRName\":\"ONCOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Frontiers in Oncology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.3389/fonc.2025.1550264","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/1 0:00:00","PubModel":"eCollection","JCR":"Q2","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0

摘要

简介:在首次临床试验之后,FLASH质子疗法(FLASH- pt)正在发展成为一种成熟的治疗方式,而FLASH效应背后的物理和生物条件仍不确定。我们的目的是通过一种新颖的方法来评估这些不确定性对临床FLASH-PT的影响。方法:通过系统的文献综述,收集相关的体内临床前研究,以及FLASH-PT的治疗方案和给药途径。这些信息用于进行影响评估:从患者选择到治疗交付的FLASH- pt过程分为几个步骤,并定义了七个FLASH条件。FLASH条件包括生理、分娩相关和放射生物学方面。对于每个步骤和FLASH状态,评分基于(i)临床应用的临界性,(ii)当前知识和(iii)可用的缓解策略。这些评分被合并以获得所有FLASH条件的总体影响,从不影响临床常规的不显著影响到导致临床翻译严重并发症的严重影响。结果:共纳入14项临床前研究和27项治疗计划研究。由此,在影响评估中报告了47个综合得分。研究发现,在放射生物学不确定的背景下,对患者的选择、闪速效应在束流暂停和中断方面的稳健性以及剂量率的评估都有严重影响,因为它们在治疗过程中与其他未知因素结合在一起很重要。分馏法和FLASH-PT治疗递送模式(传输或布拉格峰束)的影响中等至不显著,因为这些提供了规避不确定性的策略。总的来说,剂量要求、多场的使用和剂量率条件成为最关键的因素。结论:由于FLASH条件的不确定性阻碍了其在临床实践中的全部临床前潜力的利用,建议将未来的临床前实验重点放在获得进一步的现象学而不仅仅是这些方面的机制见解上。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Impact assessment of current knowledge gaps and mitigation strategies in clinical FLASH proton therapy through a systematic review.

Introduction: Following first clinical trials, the development of FLASH proton therapy (FLASH-PT) into a mature treatment modality is ongoing, while physical and biological conditions underlying the FLASH effect remain uncertain. Our aim is to assess the impact of these uncertainties on clinical FLASH-PT through a novel approach.

Methods: A systematic literature review was conducted to collect relevant in vivo preclinical studies as well as FLASH-PT treatment planning and delivery approaches. This information was used to perform an impact assessment: the FLASH-PT process from patient selection to treatment delivery was divided into steps, and seven FLASH conditions were defined. The FLASH conditions included physical, delivery-related, and radiobiological aspects. For each step and FLASH condition, scores were assigned based on the (i) criticality for clinical applications, (ii) current knowledge, and (iii) available mitigation strategies. These scores were combined to obtain an overall impact for all FLASH conditions ranging from insignificant impact not affecting clinical routine to severe impact causing severe complications for clinical translation.

Results: In total, 14 preclinical and 27 treatment planning studies were identified. From these, 47 combined scores were reported in the impact assessment. A severe impact was found for patient selection in the context of radiobiological uncertainties for the robustness of the FLASH effect with respect to beam pauses and interruptions and for the evaluation of dose rate due to their importance in the treatment process combined with remaining unknowns. Moderate to insignificant impact was found for fractionation and FLASH-PT treatment delivery mode (transmission or Bragg peak beams), as these offer strategies to circumvent uncertainties. Overall, dose requirements, the use of multiple fields, and dose rate conditions emerged as the most crucial factors.

Conclusions: Since uncertainties about the FLASH conditions hinder the utilization of its full pre-clinical potential in clinical practice, focusing future preclinical experiments to gain further phenomenological rather than only mechanistic insights on these aspects is recommended.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Frontiers in Oncology
Frontiers in Oncology Biochemistry, Genetics and Molecular Biology-Cancer Research
CiteScore
6.20
自引率
10.60%
发文量
6641
审稿时长
14 weeks
期刊介绍: Cancer Imaging and Diagnosis is dedicated to the publication of results from clinical and research studies applied to cancer diagnosis and treatment. The section aims to publish studies from the entire field of cancer imaging: results from routine use of clinical imaging in both radiology and nuclear medicine, results from clinical trials, experimental molecular imaging in humans and small animals, research on new contrast agents in CT, MRI, ultrasound, publication of new technical applications and processing algorithms to improve the standardization of quantitative imaging and image guided interventions for the diagnosis and treatment of cancer.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信